Resolution of musculoskeletal symptoms in the carcinoid syndrome after treatment with the somatostatin analog octreotide

Ann Intern Med. 1990 Jan 1;112(1):66-8. doi: 10.7326/0003-4819-112-1-66.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Bone Diseases / drug therapy*
  • Bone Diseases / etiology
  • Female
  • Humans
  • Male
  • Malignant Carcinoid Syndrome / drug therapy*
  • Middle Aged
  • Muscular Diseases / drug therapy*
  • Muscular Diseases / etiology
  • Octreotide / therapeutic use*
  • Pain / drug therapy
  • Pain / etiology

Substances

  • Octreotide